scanX
Strides Pharma Science

Strides Pharma Science

836.55
-37.55
(-4.30%)
ann
Q1 Quarterly Results are out. Check out the updated financials2 days ago
Viewcross
right
Market Cap
8,055.90 Cr
EPS
390.55
PE Ratio
21.42
Dividend Yield
0.46 %
Industry
Healthcare
52 Week High
1,675.00
52 Week Low
449.40
PB Ratio
3.16
Debt to Equity
0.94
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Strides Pharma Hits Fresh 52-Week High, Experts Target Rs 975-1,03019 hours ago
Strides Pharma Science Ltd broke out of a one-month consolidation range in July 2025, reaching a fresh 52-week high of Rs 971 on July 29, 2025. The stock's chart pattern indicates continued momentum potential. Experts suggest short-term traders consider buying the stock with targets of Rs 975-1,030 over the next 1-2 months, though the stock faced marginal resistance after hitting the high.
positive
Strides Pharma Forecasts Quarterly Operating Costs of ₹460-470 Crores, Plans Debt Elimination in 3-4 Years3 days ago
Strides Pharma has provided guidance on its financial outlook during a conference call. The company expects operating costs to remain around ₹460-470 crores each quarter. The pharmaceutical company forecasts its tax rate to be between 17-20% for the year. Additionally, Strides Pharma has outlined plans to eliminate its debt within a 3-4 year timeframe.
positive
Strides Pharma Maintains U.S. Revenue Target of $300-400 Million by 20283 days ago
Strides Pharma has reaffirmed its long-term U.S. revenue target of $300-400 million by 2028. The pharmaceutical company also expects to achieve gross margins in the range of 58-60%.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Sun Pharmaceutical
1,629.70
#1 4,09,494.50
35.67
#1 54,729.00
9.71
#1 10,980
-19.84
36.52
Divis Laboratories
6,361.50
1,75,089.80
80.00
9,712.00
0.89
2,191
23.05
30.87
Torrent Pharmaceuticals
3,678.20
1,26,642.90
62.71
11,539.40
6.99
1,911
19.91
66.62
Cipla
1,502.80
1,25,566.30
23.28
28,409.50
7.12
5,291
9.88
48.02
Dr Reddys Laboratories
1,220.60
1,06,015.60
#1 18.67
33,741.20
16.73
5,725
1.26
35.90
Mankind Pharma
2,566.30
1,05,955.70
61.04
12,744.20
#1 20.90
2,007
-18.14
54.69
Zydus Life Science
949.05
97,584.60
21.00
23,511.00
13.82
4,615
-0.19
40.50
Lupin
1,867.30
88,101.10
27.13
22,909.50
19.94
3,306
#1 112.49
37.22
Abbott
33,595.00
73,108.20
51.70
6,684.70
10.80
1,414
27.83
48.05
Aurobindo Pharma
1,079.80
66,199.80
19.18
31,378.10
17.55
3,366
-0.50
36.97
Forecast
Actual
Growth Rate
Revenue Growth
17.67 %
Net Income Growth
-384.50 %
Cash Flow Change
-2.38 %
ROE
-327.77 %
ROCE
280.68 %
EBITDA Margin (Avg.)
17.69 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
314
613
729
856
980
815
931
897
802
692
791
805
1,266
478
530
862
662
696
842
760
641
839
834
845
922
702
744
805
952
954
954
933
1,014
939
1,035
1,075
1,030
4,354
1,195
1,160
1,206
1,128
Expenses
274
564
628
728
855
676
730
602
577
595
688
627
604
448
496
516
572
612
610
574
772
648
662
712
773
850
818
833
944
1,002
844
892
879
802
1,054
886
888
866
987
946
1,000
910
EBITDA
40
50
101
128
125
140
201
295
225
97
103
178
663
30
34
346
90
84
232
187
-131
191
173
133
149
-148
-75
-28
8
-49
110
41
135
136
-18
189
142
3,488
209
215
206
218
Operating Profit %
11 %
3 %
7 %
13 %
8 %
14 %
16 %
17 %
15 %
10 %
11 %
16 %
10 %
5 %
5 %
10 %
7 %
11 %
15 %
22 %
-25 %
17 %
17 %
14 %
15 %
-23 %
-13 %
-5 %
-9 %
-7 %
6 %
-3 %
11 %
14 %
-5 %
12 %
15 %
18 %
15 %
18 %
16 %
19 %
Depreciation
20
32
36
40
39
42
44
31
38
35
37
38
44
29
31
28
30
43
42
44
45
49
53
53
52
55
57
61
61
60
62
60
61
60
60
49
48
47
49
48
49
49
Interest
15
28
34
54
62
56
58
44
48
52
49
50
46
17
17
22
23
35
40
40
40
37
37
35
42
42
44
42
50
55
68
58
81
76
79
70
71
73
74
52
50
48
Profit Before Tax
33
19
69
68
24
41
98
220
140
10
17
90
573
-16
-14
296
37
6
149
104
-217
105
83
46
55
-244
-175
-131
-103
-163
-20
-78
-7
0
-157
70
23
3,369
86
114
106
122
Tax
22
9
34
10
20
9
13
24
8
4
5
2
-5
-14
-6
-0
-8
3
7
11
-11
3
6
11
12
-36
-7
-5
-132
-28
-38
4
7
10
-7
16
13
19
14
24
21
17
Net Profit
11
10
35
58
4
33
85
196
132
6
12
88
578
-3
-9
296
45
3
142
92
-207
102
77
35
44
-209
-168
-127
29
-135
19
-82
-14
-9
-150
54
10
3,350
72
90
86
106
EPS in ₹
1.91
1.34
4.44
6.59
1.74
2.91
8.29
20.96
12.57
0.06
0.96
9.55
63.56
-0.48
-1.34
32.77
5.31
0.41
15.94
10.48
-22.77
11.56
9.03
4.22
5.14
-22.88
-18.12
-13.55
3.25
-15.13
2.54
-8.86
-1.06
-0.79
-14.54
5.43
1.98
364.64
7.81
9.56
8.92
10.81
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
2,475
7,659
8,105
6,708
7,980
6,152
7,015
6,976
6,638
5,840
6,049
Fixed Assets
701
2,499
2,980
2,977
3,648
2,099
2,219
2,347
2,311
1,865
1,899
Current Assets
1,429
3,595
3,792
2,484
3,049
2,372
2,817
3,362
3,243
2,969
3,099
Capital Work in Progress
171
1,200
780
620
453
413
447
291
151
162
207
Investments
561
1,260
1,525
588
702
549
697
540
490
303
409
Other Assets
1,041
2,700
2,821
2,524
3,177
3,091
3,651
3,798
3,687
3,510
3,534
Total Liabilities
2,475
7,659
8,105
6,708
7,980
6,152
7,015
6,976
6,638
5,840
6,049
Current Liabilities
1,020
1,940
3,104
1,899
2,662
2,545
2,738
3,412
2,990
2,879
2,592
Non Current Liabilities
291
2,813
2,119
2,191
2,516
1,012
1,463
1,181
1,475
889
871
Total Equity
1,164
2,906
2,882
2,618
2,802
2,595
2,814
2,383
2,173
2,072
2,587
Reserve & Surplus
1,085
2,774
2,659
2,374
2,559
2,438
2,687
2,269
2,105
2,034
2,460
Share Capital
60
89
89
90
90
90
90
90
90
92
92
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-288
812
-596
-259
110
-184
-56
45
133
-143
-49
Investing Activities
50
-2,205
-1,222
570
-145
1,321
-522
-119
302
-150
-90
Operating Activities
83
73
288
187
60
205
481
-258
44
701
684
Financing Activities
-421
2,944
338
-1,016
194
-1,709
-16
421
-214
-693
-643
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
29.67 %
29.62 %
29.60 %
29.60 %
30.60 %
30.37 %
31.07 %
30.89 %
28.27 %
28.07 %
27.78 %
27.39 %
25.88 %
25.86 %
25.84 %
26.82 %
28.30 %
28.30 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.05 %
0.05 %
0.05 %
0.05 %
0.00 %
0.00 %
24.57 %
26.71 %
30.08 %
28.48 %
28.32 %
28.02 %
DIIs
14.82 %
13.23 %
14.22 %
14.85 %
12.40 %
9.82 %
13.59 %
18.84 %
18.29 %
20.00 %
18.22 %
17.56 %
18.04 %
18.56 %
18.24 %
16.92 %
13.72 %
13.30 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
14.01 %
16.64 %
17.89 %
20.42 %
21.82 %
22.29 %
22.40 %
22.43 %
25.51 %
24.93 %
23.39 %
22.65 %
21.19 %
20.87 %
18.57 %
20.86 %
21.52 %
22.10 %
Others
41.49 %
40.51 %
38.29 %
35.12 %
35.19 %
37.51 %
32.88 %
27.77 %
27.86 %
26.93 %
30.60 %
32.39 %
10.32 %
8.00 %
7.26 %
6.90 %
8.14 %
8.27 %
No of Share Holders
74,074
96,976
1,06,927
1,25,553
1,33,190
1,34,718
1,30,682
1,23,964
1,20,916
1,12,775
1,01,638
91,182
84,695
91,917
96,009
1,14,236
95,125
92,889

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 4.5 2 3 0.00 0.00 0.00 0.00 2.5 4
Dividend Yield (%) 0.00 0.69 0.42 0.93 0.00 0.00 0.00 0.00 0.37 0.48

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
07 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 07 Aug 2025 865.50 836.95
29 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 29 Jul 2025 877.90 922.50
22 Jul 2025 DIVIDEND Dividend
₹ 4.00 /share
 22 Jul 2025 694.95 889.65
22 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 22 May 2025 663.35 694.95
30 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Jan 2025 628.20 608.70
24 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 24 Oct 2024 720.09 683.70
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 25 Sept 2024 597.53 611.51
10 Sept 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
 10 Sept 2024 488.59 572.84
09 Sept 2024 DIVIDEND Dividend
₹ 2.50 /share
 09 Sept 2024 370.78 595.84
28 Aug 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
 28 Aug 2023 193.07 192.90
04 Aug 2023 DIVIDEND Dividend
₹ 1.50 /share
 04 Aug 2023 165.46 194.41
06 Aug 2021 DIVIDEND Dividend
₹ 2.50 /share
 05 Aug 2021 356.19 342.54
18 Jul 2018 CHANGE OF NAME Change Of Name
NA
 18 Jul 2018 157.75 157.75

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome3 days ago
Board Meeting Outcome for Allotment Of Shares Under ESOP Scheme3 days ago
Amendment To Code Of Fair Disclosure Of UPSI3 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS3 days ago
Financial Results (Consolidated & Standalone) For The Quarter Ended June 30 20253 days ago
Change In Statutory Auditors Of Material Subsidiary Of The Company In UK4 days ago
Reminder To Shareholders About Transfer Of Equity Shares Relating To Unclaimed Dividend Of The Company To Investor Education And Protection Fund (IEPF)6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20159 days ago
Announcement under Regulation 30 (LODR)-Change in Management10 days ago
Business Responsibility and Sustainability Reporting (BRSR)Jul 11, 2025
Reg. 34 (1) Annual Report.Jul 11, 2025
Notice Of 34Th Annual General MeetingJul 11, 2025
No Objection Letter Received From Stock Exchanges.Jul 10, 2025
Intimation Regarding Communication To Shareholders On TDS For Final Dividend For FY 2024-25Jul 10, 2025
Intimation Regarding Communication To Shareholders On TDS For Final Dividend For FY 2024-25Jul 10, 2025
Intimation To Members About Record Date For The Purpose Of Final Dividend For FY25.Jul 09, 2025
Closure of Trading WindowJun 27, 2025
Intimation Pursuant To Regulation 31AJun 27, 2025
Announcement under Regulation 30 (LODR)-RestructuringJun 16, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Intimation Pursuant To Regulation 31A Of The Sebl (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Promoter ReclassificationMay 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On May 22 2025May 22, 2025
Update On Promoters Reclassification RequestMay 22, 2025
Appointment Of Secretarial AuditorMay 22, 2025
Corporate Action-Board approves DividendMay 22, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 22, 2025
Outcome Of Board Meeting Of The Company Held On May 22 2025May 22, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementMay 15, 2025
Intimation Under Regulation 31A Of SEBI Listing RegulationsMay 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
Board Meeting Intimation for Intimation On Board MeetingMay 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 30, 2025
Strides Acquires Identified Andas From Nostrum Laboratories Inc. USAApr 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 11, 2025
Intimation For Change In Details Of Key Managerial Personnel For Determining Materiality Of Events Or Information And Making Disclosure To Stock Exchange Under Regulation 30 Of SEBI Listing RegulationsApr 03, 2025
Update On Redemption Of Secured Unlisted Redeemable Non-Convertible DebenturesApr 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 21, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 21, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 19, 2025
Proposed De-Merger Of Identified Business Of Arco Lab Private Limited (Arco Lab) A Wholly Owned Subsidiary Of The CompanyMar 19, 2025
DissolutionMar 18, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 14, 2025

Technical Indicators

RSI(14)
Neutral
41.03
ATR(14)
Volatile
39.25
STOCH(9,6)
Neutral
51.56
STOCH RSI(14)
Neutral
25.97
MACD(12,26)
Bearish
-7.61
ADX(14)
Strong Trend
32.46
UO(9)
Bearish
39.67
ROC(12)
Downtrend And Accelerating
-7.69
WillR(14)
Oversold
-87.19
Bearish
3
Neutral
5
Bullish
1

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
1.10%
-12500
-0.29%
0.21%
WhiteOak Capital Special Opportunities Fund Direct - Growth
0.57%
-4776
-0.04%
0.03%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.76%
1644
0.04%
0.11%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.44%
-10
0.01%
0.09%
Angel One Nifty Total Market Index Fund Direct - Growth
0.03%
8
0.00%
0.01%
Groww Nifty Total Market Index Fund Direct - Growth
0.03%
-8
0.00%
0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.03%
-5
0.00%
0.01%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.03%
-2
0.00%
0.01%
JM ELSS Tax Saver Fund Direct Plan-Growth
0.00%
0
0.00%
0.00%
Mirae Asset Healthcare Fund Direct - Growth
0.00%
0
0.00%
0.00%
Axis Value Fund Direct-Growth
0.00%
0
0.00%
0.00%
Axis Flexi Cap Fund Direct-Growth
0.26%
0
0.02%
0.06%
Bandhan Midcap Fund Direct-Growth
0.23%
0
0.01%
0.04%
Axis Equity Savings Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Small Cap Fund Direct-Growth
0.62%
0
0.00%
0.02%
Axis Business Cycles Fund Direct-Growth
0.00%
0
0.00%
0.00%
ITI Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
ITI Pharma and Healthcare Fund Direct - Growth
1.08%
0
0.07%
0.26%
Aditya Birla Sun Life Flexi Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
JM Flexicap Fund Direct Plan-Growth
0.00%
0
0.00%
0.00%
JM Midcap Fund Direct - Growth
0.00%
0
0.00%
0.00%
JM Small Cap Fund Direct - Growth
1.30%
0
0.06%
0.08%
Mirae Asset Flexi Cap Fund Direct - Growth
0.00%
0
0.00%
0.00%
Axis Small Cap Fund Direct-Growth
0.25%
0
0.01%
0.05%
Aditya Birla Sun Life Value Direct Fund-Growth
0.84%
0
0.06%
0.18%
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Intraday Screeners
Candlestick Screeners
Fundamental Screeners
Technical Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2025 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104